Literature DB >> 25684746

Anti-Gal IgM, IgA and IgG natural antibodies in childhood.

Marketa Hamanova1, Magda Chmelikova1, Ivo Nentwich2, Vojtech Thon3, Jindrich Lokaj1.   

Abstract

The target for the most abundant xenoreactive natural antibodies in humans is the α-Gal epitope. Anti-Gal could provide natural immune defense against pathogens that express the α-Gal epitope. Anti-Gal natural antibodies are usually studied in adult individuals. Data demonstrating the incidence and concentration of anti-Gal natural antibodies in childhood are in short supply and incomplete. In the present study we prospectively quantified anti-Gal IgM, IgA and IgG levels in different age groups of children from delivery to 24 months of age and compared these levels to the level of these antibodies in their respective mothers. Measurement of anti-Gal antibodies may broaden the spectrum of specific antibodies that are available for determination of specific antibody responses in physiological and pathological conditions in children. Plasma was collected from umbilical cord blood of full term newborn, from blood of infants at age 6, 12 and 24 months and from their respective mothers at time of delivery. Quantitative determination of anti-Gal antibodies IgM, IgA and IgG were made with the enzyme immunoassays Human Anti-Alpha Galactosyl IgM ELISA, IgG ELISA and IgA ELISA. Hemagglutination activity was titrated against rabbit erythrocytes. The kinetic processes for the formation of natural antibodies in the first two years of life, in general, compared with the kinetics for the formation of total immunoglobulins IgM, IgA and IgG. There were no detectable anti-Gal IgM and IgA in the cord blood, whereas anti-Gal IgG were found at similar levels in both neonate cord blood and peripheral blood of their respective mothers. When comparing the percentage of natural antibodies in the plasma of children, the level of natural antibodies in children at the age of two years was approximately 37% for IgM, 25% for IgG and 15% for IgA. The titration of antibodies required for agglutination of rabbit red blood cells over the 24 month period followed the same trend observed for the formation of natural antibodies. Our study demonstrates the kinetics of formation of anti-Gal IgM, IgA and IgG natural antibodies in the first two years of life. The relative lack of these antibodies in this period should be taken into account when assessing for humoral immunodeficiencies, particularly with regards to the potential for children to mount an anti-carbohydrate response.
Copyright © 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-Gal; Childhood; Immunodeficiency; Kinetics; Natural antibodies

Mesh:

Substances:

Year:  2015        PMID: 25684746     DOI: 10.1016/j.imlet.2015.02.001

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  12 in total

Review 1.  Glycan Reactive Natural Antibodies and Viral Immunity.

Authors:  J Stewart New; R Glenn King; John F Kearney
Journal:  Viral Immunol       Date:  2019-12-17       Impact factor: 2.257

2.  On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.

Authors:  Thomas A E Platts-Mills; Scott P Commins; Tilo Biedermann; Marianne van Hage; Michael Levin; Lisa A Beck; Maria Diuk-Wasser; Uta Jappe; Danijela Apostolovic; Michael Minnicozzi; Marshall Plaut; Jeffrey M Wilson
Journal:  J Allergy Clin Immunol       Date:  2020-02-10       Impact factor: 10.793

3.  Effect of enriched housing on levels of natural (auto-)antibodies in pigs co-infected with porcine reproductive and respiratory syndrome virus (PRRSV) and Actinobacillus pleuropneumoniae.

Authors:  Lu Luo; Ingrid Daniëlle Ellen van Dixhoorn; Inonge Reimert; Bas Kemp; Jantina Elizabeth Bolhuis; Hendrik Karel Parmentier
Journal:  Vet Res       Date:  2017-11-10       Impact factor: 3.683

4.  Effect of blood type on anti-α-Gal immunity and the incidence of infectious diseases.

Authors:  Alejandro Cabezas-Cruz; Lourdes Mateos-Hernández; Pilar Alberdi; Margarita Villar; Gilles Riveau; Emmanuel Hermann; Anne-Marie Schacht; Jamal Khalife; Margarida Correia-Neves; Christian Gortazar; José de la Fuente
Journal:  Exp Mol Med       Date:  2017-03-10       Impact factor: 8.718

5.  Limited Neonatal Carbohydrate-Specific Antibody Repertoire Consecutive to Partial Prenatal Transfer of Maternal Antibodies.

Authors:  Katharina Kappler; Tanja Restin; Yi Lasanajak; David F Smith; Dirk Bassler; Thierry Hennet
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

Review 6.  Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease.

Authors:  Peter Isaac Lobo
Journal:  Front Immunol       Date:  2016-06-06       Impact factor: 7.561

Review 7.  Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).

Authors:  Guoli Huai; Ping Qi; Hongji Yang; Yi Wang
Journal:  Int J Mol Med       Date:  2015-10-30       Impact factor: 4.101

8.  Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies.

Authors:  P Kralickova; J Kuhnova; O Soucek; P Vodarek; P Zak; M Simkovic; M Motyckova; L Smolej; E Mala; C Andrys; J Krejsek; V Thon
Journal:  J Immunol Res       Date:  2017-12-17       Impact factor: 4.818

9.  Antibody responses to α-Gal in African children vary with age and site and are associated with malaria protection.

Authors:  Ruth Aguilar; Itziar Ubillos; Marta Vidal; Núria Balanza; Núria Crespo; Alfons Jiménez; Augusto Nhabomba; Chenjerai Jairoce; David Dosoo; Ben Gyan; Aintzane Ayestaran; Hèctor Sanz; Joseph J Campo; Gloria P Gómez-Pérez; Luis Izquierdo; Carlota Dobaño
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

Review 10.  Emergence and significance of carbohydrate-specific antibodies.

Authors:  Katharina Kappler; Thierry Hennet
Journal:  Genes Immun       Date:  2020-08-05       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.